Picture of Cingulate logo

CING — Cingulate News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Cingulate Receives $4.3M Waiver From FDA Ahead Of Imminent Filing For Marketing Approval Of Lead Adhd Asset Ctx-1301

July 29 (Reuters) - Cingulate Inc CING.O:

CINGULATE RECEIVES $4.3M WAIVER FROM FDA AHEAD OF IMMINENT FILING FOR MARKETING APPROVAL OF LEAD ADHD ASSET CTX-1301

Source text: ID:nGNX1P2kYp

Further company coverage: CING.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cingulate

See all news